Yangyang Han | Nanomaterials | Research Excellence Award

Prof. Yangyang Han | Nanomaterials | Research Excellence Award

Shandong Second Medical University, China

Prof. Yangyang Han is a distinguished scholar and influential educator whose work spans biochemistry, molecular biology, and biomechanics. He holds a Ph.D. and has built a strong academic foundation that supports his role as a Professor and Master’s Supervisor. Over the years, he has served in several notable capacities, including Associate Professor, Lecturer, and Senior Visiting Scholar at the Institute of Mechanics, Chinese Academy of Sciences, where he deepened his expertise in molecular mechanisms and biomechanical processes. His professional journey includes leadership as Director of the Molecular Biology Teaching and Research Section and service as a Review Expert for the National Natural Science Foundation of China, reflecting his credibility in scientific evaluation and research guidance. As Leader of the Youth Innovation Team of Shandong Provincial Institutions of Higher Education and a Director within the Shandong Society of Biochemistry and Molecular Biology, he continues to foster scientific development and interdisciplinary collaboration. His research interests focus on molecular regulation, cellular biomechanics, and biomedical innovation, contributing to impactful advancements in the field. With recognition for his academic leadership and scientific service, Prof. Han remains committed to driving research excellence, nurturing emerging scholars, and advancing knowledge in life sciences.

Profiles: Scopus | Orcid

Featured Publications

Bai, L., Qian, X., Zhang, H., Yuan, Y., Cui, X., Cheng, M., & Han, Y. (2025). Plectin, a novel regulator in migration, invasion and adhesion of ovarian cancer. Cell & Bioscience. https://doi.org/10.1186/s13578-025-01349-2

Han, Y. (2020). RNA-seq reveals the diverse effects of substrate stiffness on epidermal ovarian cancer cells. Aging. https://doi.org/10.18632/aging.103906

Han, Y. (2020). Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia. Cell Death Discovery. https://doi.org/10.1038/s41420-020-0269-0

 

Nicholas Candy | Surgical Hydrogels | Research Excellence Award

Dr. Nicholas Candy | Surgical Hydrogels | Research Excellence Award

University of Adelaide | Australia

Dr. Nicholas Candy is an accomplished neurosurgeon and academic whose career blends advanced clinical expertise with impactful research. He holds a Master of Surgery in Neurosurgery from the University of Sydney and completed his PhD at the University of Adelaide, where he later progressed to roles as Clinical Lecturer and Senior Clinical Lecturer. His extensive clinical experience spans multiple accredited registrar positions across leading Australian hospitals, including the Royal Adelaide Hospital, Royal Brisbane and Women’s Hospital, and Flinders Medical Centre. He has cultivated strong research interests in pituitary surgery, postoperative outcomes, neuro-endocrine preservation, and innovations that reduce surgical scarring and complications. His role as Coordinating Principal Investigator in a Phase I trial on Chitogel and Deferiprone Gel reflects his commitment to translational research designed to enhance neurosurgical recovery. Dr. Candy has supervised doctoral research, contributed to international clinical studies, and carried out significant work in traumatic brain injury outcomes and neurosurgical quality-of-life assessments. His academic impact and contributions have earned him notable awards, including multiple prestigious research scholarships from the Royal Australasian College of Surgeons and recognition as the Sheldon College Young Alumnus of the Year. Overall, he stands out as a dedicated clinician-scientist advancing modern neurosurgical practice.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Ovenden, C., Mignone, E., Chapman, I., Torpy, D. J., Rankin, W., Jukes, A., Santoreneos, S., Candy, N., Psaltis, A., & De Sousa, S. M. C. (2026). “Early Postoperative Decline in Insulin-Like Growth Factor 1 (IGF-1) Predicts Surgical Remission of Acromegaly.” World Neurosurgery.

Candy, N. G., Barry, E. F., Tomatis, V. M., Patel, S., Miller, J., Ovenden, C., Nowicki, J., Hammam, E., Poonnoose, S., Sandler, S., et al. (2025). “Phase I Trial to Evaluate Safety of Deferiprone-Chitogel to Prevent Epidural Fibrosis in Lumbar Spine Surgery.” European Spine Journal.

Tong, J. Y., Candy, N. G., Sung, J., Jukes, A. K., & Selva, D. (2025). “In Reply: Transorbital Approach to the Cavernous Sinus After an Exenteration.” Operative Neurosurgery.

Tong, J. Y., Candy, N. G., Sung, J., Jukes, A. K., & Selva, D. (2025). “Transorbital Approach to the Cavernous Sinus After an Exenteration.” Operative Neurosurgery.

Candy, N. G., Jukes, A. K., Ooi, E. H., Valentine, R., Vrodos, N., Santoreneos, S., Floreani, S., Wormald, P.-J., & Psaltis, A. J. (2025). “The Evolution of Pituitary Surgery in an Australian Health Care Framework.” Journal of Neurological Surgery Part B: Skull Base.

Candy, N. G., Zhang, A. S., Jukes, A. K., & Wormald, P. J. (2025). “Sphenoid sinusitis with extradural empyema in a paediatric patient.” Journal of Clinical Neuroscience.

Mansour, L. T., Candy, N., Nowicki, J., Jukes, A., Chryssidis, S., & Harding, M. (2024). “An infratentorial dural arteriovenous fistula mimicking cervical myelopathy: A case report.” Clinical Neurology and Neurosurgery.